Skip to main content
Top
Published in: Journal of Clinical Immunology 8/2022

23-07-2022 | Peeling | Correction

Correction to: Peeling Skin Syndrome Type 1: Dupilumab Reduces IgE, But Not Skin Anomalies

Authors: Alexis Barranca, Nathalie Jonca, Audrey Martin-Blondel, Pol-André Apoil, Juliette Mazereeuw-Hautier

Published in: Journal of Clinical Immunology | Issue 8/2022

Login to get access

Excerpt

Correction to : Journal of Clinical Immunology (2022) 42:873–875
Metadata
Title
Correction to: Peeling Skin Syndrome Type 1: Dupilumab Reduces IgE, But Not Skin Anomalies
Authors
Alexis Barranca
Nathalie Jonca
Audrey Martin-Blondel
Pol-André Apoil
Juliette Mazereeuw-Hautier
Publication date
23-07-2022
Publisher
Springer US
Keywords
Peeling
Dupilumab
Published in
Journal of Clinical Immunology / Issue 8/2022
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-022-01309-2

Other articles of this Issue 8/2022

Journal of Clinical Immunology 8/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.